최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
DataON 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Edison 바로가기다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
Kafe 바로가기국가/구분 | United States(US) Patent 등록 |
---|---|
국제특허분류(IPC7판) |
|
출원번호 | UP-0078949 (2002-02-20) |
등록번호 | US-7695902 (2010-05-20) |
발명자 / 주소 |
|
출원인 / 주소 |
|
대리인 / 주소 |
|
인용정보 | 피인용 횟수 : 137 인용 특허 : 401 |
Oligomeric compounds including oligoribonucleotides and oligoribonucleosides are provided that have subsequences of 2′-pentoribofuranosyl nucleosides that activate dsRNase. The oligoribonucleotides and oligoribonucleosides can include substituent groups for increasing binding affinity to comp
Oligomeric compounds including oligoribonucleotides and oligoribonucleosides are provided that have subsequences of 2′-pentoribofuranosyl nucleosides that activate dsRNase. The oligoribonucleotides and oligoribonucleosides can include substituent groups for increasing binding affinity to complementary nucleic acid strand as well as substituent groups for increasing nuclease resistance. The oligomeric compounds are useful for diagnostics and other research purposes, for modulating the expression of a protein in organisms, and for the diagnosis, detection and treatment of other conditions susceptible to oligonucleotide therapeutics. Also included in the invention are mammalian ribonucleases, i.e., enzymes that degrade RNA, and substrates for such ribonucleases. Such a ribonuclease is referred to herein as a dsRNase, wherein “ds” indicates the RNase's specificity for certain double-stranded RNA substrates. The artificial substrates for the dsRNases described herein are useful in preparing affinity matrices for purifying mammalian ribonuclease as well as non-degradative RNA-binding proteins.
What is claimed is: 1. A method of activating a double-stranded RNA nuclease, comprising: (i) contacting the nuclease with a double-stranded oligomeric compound comprising a first oligonucleotide and a second oligonucleotide, wherein: at least one of said first and said second oligonucleotides comp
What is claimed is: 1. A method of activating a double-stranded RNA nuclease, comprising: (i) contacting the nuclease with a double-stranded oligomeric compound comprising a first oligonucleotide and a second oligonucleotide, wherein: at least one of said first and said second oligonucleotides comprises at least four consecutive 2′-hydroxyl ribonucleosides and at least one chemical modification; said first and said second oligonucleotides are hybridized to each other; said first and said second oligonucleotides are not covalently linked to each other; and wherein said first and said second oligonucleotides are each independently from 15 to 25 nucleoside subunits in length; and (ii) detecting activation of said double-stranded RNA nuclease. 2. The method of claim 1, wherein the at least one chemical modification increases resistance of said oligonucleotide to single-stranded nucleases and/or increases the affinity of said oligonucleotide to the other oligonucleotide. 3. Tbe method of claim 2, wherein at least one modification is 2′-methoxy. 4. The method of claim 2, wherein at least one modification is 2′-fluoro. 5. The method of claim 2, wherein at least one modification is 2′-O-methoxyethyl. 6. The method of claim 2, wherein at least one modification is a phosphorothioate internucleoside linkage. 7. The method of claim 1, wherein said first oligonucleotide and said second oligonucleotide each have at least four consecutive 2′-hydroxyl ribonucleosides. 8. The method of claim 7, wherein the 2′-hydroxyl residues of said first and said second oligonucleotides have phosphodiester linkages. 9. The method of claim 7, wherein the 2′-hydroxyl residues of said first and said second oligonucleotides have phosphorothioate linkages. 10. The method of claim 7, wherein the 2′-hydroxyl residues of said first oligonucleotide have phosphodiester linkages and the 2′-hydroxyl residues of said second oligonucleotide have phosphorothioate linkages. 11. The method of claim 7 or claim 10, wherein said first and said second oligonucleotides further comprise flanking residues 5′ and 3′ of the 2′-hydroxyl ribonucleosides, wherein said flanking residues have phosphorothioate linkages. 12. The method of claim 11, wherein said flanking residues of at least one of said first and said second oligonucleotides further comprises 2′-methoxynucleosides. 13. The method of claim 11, wherein said flanking residues of each of said first and said second oligonucleotides further comprise 2′-methoxynucleosides. 14. The method of claim 1, wherein at least one of said first and said second oligonucleotides comprises at least eight consecutive 2′-hydroxyl ribonucleosides. 15. The method of claim 14, wherein said first oligonucleotide and said second oligonucleotide each comprise at least eight consecutive 2′-hydroxyl ribonucleotides. 16. The method of claim 1, wherein each of said first and said second oligonucleotides are about 17 to about 20 nucleoside subunits in length. 17. The method of claim 16, wherein each of said first and said second oligonucleotides are 17 subunits in length. 18. The method of claim 16, wherein each of said first and said second oligonucleotides are 20 subunits in length. 19. A method of activating a double-stranded RNA nuclease comprising contacting the double-stranded RNA nuclease with a double-stranded oligomeric compound comprising a first oligonucleotide and a second oligonucleotide, wherein: said first and said second oligonucleotides are each independently 15 to 25 nucleoside subunits in length; said first and said second oligonucleotides are hybridized to each other; said first and said second oligonucleotides are not covalently linked to each other; and at least one of said first and said second oligonucleotides comprises at least four consecutive 2′-hydroxyl ribonucleosides and at least one chemical modification. 20. The method of claim 19 wherein at least one chemical modification increases resistance to single-stranded nucleases. 21. The method of claim 19 wherein at least one chemical modification increases affinity of said first oligonucleotide to said second oligonucleotide. 22. The method of claim 19 wherein at least one chemical modification is a modified internucleoside linkage, a modified sugar moiety or a modified nucleobase. 23. The method of claim 19 wherein at least one chemical modification is a phosphorothioate internucleoside linkage. 24. The method of claim 19 wherein at least one chemical modification is a 2′-substituted sugar modification. 25. The method of claim 19 wherein at least one chemical modification is a 2′-alkoxy sugar modification. 26. The method of claim 19 wherein at least one cbexnical modification is a 2′-methoxy sugar modification. 27. The method of claim 19 wherein at least one chemical modification is a 2′-fluoro sugar modification. 28. The method of claim 19 wherein at least one chemical modification is a 2′-O-methoxyethyl sugar modification. 29. The method of claim 19 wherein each of said first and said second oligonucleotides comprises at least four consecutive 2′-hydroxyl ribonucleosides. 30. The method of claim 19 wherein each of said first and said second oligonucleotides comprises at least one chemical modification. 31. The method of claim 19 wherein each of said first and said second oligonucleotides comprises at least four consecutive 2′-hydroxyl ribonucleosides and at least one chemical modification. 32. The method of claim 19 wherein said first oligonucleotide and said second oligonucleotide comprise at least 17 contiguous nucleotides which are 100% complementary to each other. 33. The method of claim 19 wherein said first oligonucleotide is 100% complementary to said second oligonucleotide. 34. The method of claim 19 wherein said first oligonucleotide and said second oligonucleotide are independently 17 to 20 riucleoside subunits in length. 35. The method of claim 19 further comprising detecting activation of said double-stranded RNA nuclease. 36. A method of activating a double-stranded RNA nuclease comprising contacting the double-stranded RNA nuclease with a double-stranded oligomeric compound comprising a first oligonucleotide and a second oligonucleotide, wherein: said first and said second oligonucleotides are each independently 15 to 25 nucleoside subunits in length; said first and said second oligonucleotides are hybridized to each other; said first and said second oligonucleotides are not covalently linked to each other; and at least one of said first and said second oligonucleotides comprises: a plurality of nucleoside subunits with 2′-hydroxyl pentofuranosyl sugar moieties; and at least one chemical modification. 37. The method of claim 36 wherein at least one chemical modification increases resistance to single-stranded nucleases. 38. The method of claim 36 wherein at least one chemical modification increases affinity of said first oligonucleotide to said second oligonucleotide. 39. The method of claim 36 wherein at least one chemical modification is a modified internucleoside linkage, a modified sugar moiety or a modified nucleobase. 40. The method of claim 36 wherein at least one chemical modification is a phosphorothioate internucleoside linkage. 41. The method of claim 36 wherein at least one chemical modification is a 2′-substituted sugar modification. 42. The method of claim 36 wherein at least one chemical modification is a 2′-alkoxy sugar modification. 43. The method of claim 36 wherein at least one chemical modification is a 2′-methoxy sugar modification. 44. The method of claim 36 wherein at least one chemical modification is a 2′-fluoro sugar modification. 45. The method of claim 36 wherein at least one chemical modification is a 2′O-methoxyethyl sugar modification. 46. The method of claim 36 wherein each of said first and said second oligonucleotides comprises a plurality of nucleoside subunits with 2′-hydroxyl pentofuranosyl sugar moieties. 47. The method of claim 36 wherein each of said first and said second oligonucleotides comprises at least one chemical modification. 48. The method of claim 36 wherein each of said first and said second oligonucleotides comprises a plurality of nucleoside subunits with 2′-hydroxyl pentofuranosyl sugar moieties and at least one chemical modification. 49. The method of claim 36 wherein said first oligonucleotide and said second oligonucleotide comprise at least 17 contiguous nucleotides which are 100% complementary to each other. 50. The method of claim 36 wherein said first oligonucleotide is 100% complementary to said second oligonucleotide. 51. The method of claim 36 wherein said first oligonucleotide and said second oligonucleotide are independently 17 to 20 nucleoside subunits in length. 52. The method of claim 36 further comprising detecting activation of said double-stranded RNA nuclease. 53. A method of activating a double-stranded RNA nuclease comprising contacting the double-stranded RNA nuclease with a double-stranded oligomeric compound comprising a first oligonucleotide and a second oligonucleotide, wherein: said first and said second oligonucleotides are hybridized to each other; said first and said second oligonucleotides are not covalently linked to each other; said first and said second oligonucleotides are each independently from 15 to 25 nucleoside subunits in length; and each of said first and said second oligonucleotides comprises at least four consecutive 2′-hydroxyl ribonucleosides and at least one chemical modification. 54. The method of claim 53 wherein at least one chemical modification increases resistance to single-stranded nucleases. 55. The method of claim 53 wherein at least one chemical modification increases affinity of said first oligonucteotide to said second oligonucleotide. 56. The method of claim 53 wherein at least one chemical modification is a modified internuoleoside linkage, a modified sugar moiety or a modified nucleobase. 57. The method of claim 53 wherein at least one chemical modification is a phosphorothioat internucleoside linkage. 58. The method of claim 53 wherein at least one chemical modification is a 2′-substituted sugar modification. 59. The method of claim 53 wherein at least one chemical modification is a 2′-alkoxy sugar modification. 60. The method of claim 53 wherein at least one chemical modification is a 2′-methoxy sugar modification. 61. The method of claim 53 wherein at least one chemical modification is a 2′-fiuoro sugar modification. 62. The method of claim 53 wherein at least one chemical modification is a 2′-O-methoxyethyl sugar modification. 63. The method of claim 53 further comprising detecting activation of said double-stranded RNA nuclease. 64. A method of activating a double-stranded RNA nuclease comprising contacting the double-stranded RNA nuclease with a double-stranded oligomeric compound comprising a first oliganucleotide and a second oligonucleotide, wherein: said first and said second oligonucleotides are hybridized to each other; said first and said second oligonucleotides are not covalently linked to each other; said first and said second oligonucleotides are 100% complementary to each other; and at least one of said first and said second oligonucleotides comprises at least four consecutive 2′-hydroxyl ribonucleosides and at least one chemical modification. 65. The method of claim 64 wherein at least one chemical modification increases resistance to single-stranded nucleases. 66. The method of claim 64 wherein at least one chemical modification increases affinity of said first oligonucleotide to said second oligonucleotide. 67. The method of claim 64 wherein at least one chemical modification is a modified internucleoside linkage, a modified sugar moiety or a modified nucleobase. 68. The method of claim 64 wherein at least one chemical modification is a phosphorothioate internucleoside linkage. 69. The method of claim 64 wherein at least one chemical modification is a 2′-substituted sugar modification. 70. The method of claim 64 wherein at least one chemical modification is a 2′-alkoxy sugar modification. 71. The method of claim 64 wherein at least one chemical modification is a 2′-methoxy sugar modification. 72. The method of claim 64 wherein at least one chemical modification is a 2′-fluoro sugar modification. 73. The method of claim 64 wherein at least one chemical modification is a 2′-O-methoxyethyl sugar modification. 74. The method of claim 64 further comprising detecting activation of said double-stranded RNA nuclease. 75. The method of claim 36, wherein the double-stranded RNA nuclease is not in a cell.
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.